Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
21,34 USD | -0,74 % | -14,67 % | -30,01 % |
25/03 | Intellia Therapeutics pone fin al acuerdo de desarrollo con Regeneron Pharmaceuticals | MT |
22/03 | Intellia Therapeutics pone fin al acuerdo de desarrollo con Regeneron Pharmaceuticals | MT |
Resumen de negocios
Número de empleados: 526
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Genome Editing-based Therapies
100,0
%
| 52 | 100,0 % | 36 | 100,0 % | -30,40 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 52 | 100,0 % | 36 | 100,0 % | -30,40 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
John Leonard
CEO | Chief Executive Officer | 66 | 01/07/14 |
Glenn Goddard
DFI | Director of Finance/CFO | 53 | 29/10/18 |
Eliana Clark
CTO | Chief Tech/Sci/R&D Officer | 67 | - |
Chief Tech/Sci/R&D Officer | 63 | 28/05/19 | |
David Lebwohl
CTO | Chief Tech/Sci/R&D Officer | 69 | 30/04/20 |
Li Lina
IRC | Investor Relations Contact | - | - |
- | - | ||
Aron Stein
LAW | General Counsel | - | - |
Derek Hicks
PRN | Corporate Officer/Principal | 51 | 20/12/21 |
Marika St Amand
HRO | Human Resources Officer | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Fred Cohen
BRD | Director/Board Member | 67 | 24/01/19 |
John Leonard
CEO | Chief Executive Officer | 66 | 01/07/14 |
Frank Verwiel
CHM | Chairman | 62 | 24/07/17 |
William Chase
BRD | Director/Board Member | 57 | 14/04/23 |
Jesse Goodman
BRD | Director/Board Member | 72 | 31/10/18 |
Georgia Keresty
BRD | Director/Board Member | 62 | 09/04/21 |
Muna Bhanji
BRD | Director/Board Member | 61 | 28/04/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 96 106 405 | 94 824 319 ( 98,67 %) | 0 | 98,67 % |
Información de la empresa
Intellia Therapeutics, Inc.
40 Erie Street Suite 130
02139, Cambridge
+857 285 6200
http://www.intelliatx.comSector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-30,01 % | 2073,43 M | |
-1,82 % | 41,36 mil M | |
+44,25 % | 41,3 mil M | |
+2,56 % | 39,61 mil M | |
-12,11 % | 25,62 mil M | |
+3,09 % | 24,09 mil M | |
-24,16 % | 18,38 mil M | |
+22,12 % | 11,85 mil M | |
-3,74 % | 11,82 mil M | |
+7,75 % | 11,07 mil M |
- Bolsa de valores
- Acciones
- Acción NTLA
- Empresa Intellia Therapeutics, Inc.